Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Prepaid Assets (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Prepaid Assets data on record, last reported at $421924.0 in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 138.6% year-over-year to $421924.0; the TTM value through Sep 2025 reached $421924.0, up 138.6%, while the annual FY2024 figure was $159692.0, 78.47% down from the prior year.
  • Prepaid Assets reached $421924.0 in Q3 2025 per GANX's latest filing, up from $261365.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.6 million in Q3 2022 and bottomed at $33109.0 in Q2 2021.
  • Average Prepaid Assets over 5 years is $598274.5, with a median of $506583.0 recorded in 2023.
  • Peak YoY movement for Prepaid Assets: soared 2002.27% in 2022, then crashed 80.5% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $498252.0 in 2021, then crashed by 58.15% to $208542.0 in 2022, then skyrocketed by 255.63% to $741638.0 in 2023, then crashed by 78.47% to $159692.0 in 2024, then skyrocketed by 164.21% to $421924.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $421924.0 in Q3 2025, $261365.0 in Q2 2025, and $841446.0 in Q1 2025.